Search
Search Results
##search.searchResults.foundPlural##
-
TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin
1466PDF: 1146HTML: 477 -
FOLLICULAR LYMPHOMA: THE MANAGEMENT OF ELDERLY PATIENT
4782PDF: 1753HTML: 4353Tables and Images: 301 -
THE ROLE OF INFECTION IN THE PATHOGENESIS OF VASO-OCCLUSIVE CRISIS IN PATIENTS WITH SICKLE CELL DISEASE.
5586PDF: 1433HTML: 2894Cover letter: 250 -
Common parasite with uncommon associations
1601PDF: 757HTML: 1869 -
COAGULOPATHY IN BETA-THALASSEMIA: CURRENT UNDERSTANDING AND FUTURE PERSPECTIVES
1420PDF: 542HTML: 8367 -
IMPACT OF QUALITATIVE AND QUANTITATIVE IMMUNOPARESIS ON EARLY INFECTION RISK IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA Immunoparesis and early infection risk in myeloma
285PDF: 799HTML: 79 -
EPIDEMIOLOGICAL AND CLINICAL CHARACTERISTICS OF PEDIATRIC COVID-19 IN THE TERTIARY CARE SYSTEM IN THAILAND: COMPARATIVE DELTA AND PRE-DELTA ERA Pediatric COVID-19 in Thailand during pre-Delta and Delta era
1245PDF: 671HTML: 299 -
MAGNUSIOMYCES CAPITATUS BREAKTHROUGH INFECTION IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS RECEIVING ECHINOCANDIN PROPHYLAXIS: CLINICAL FEATURES, MANAGEMENT, AND REVIEW OF THE LITERATURE
177PDF: 239Suppl. Files: 45Html: 121Html Suppl. Files: 109 -
Pathologic splenic rupture in a patient with follicular lymphoma
1527PDF: 631HTML: 1238rupture: 228 -
How I treat acute and persistent sickle cell pain
2174PDF: 1209HTML: 805 -
RELIABILITY OF DIFFERENT RBC INDICES AND FORMULAS IN DISCRIMINATING BETWEEN ?-THALASSEMIA MINOR AND OTHER CAUSES OF MICROCYTIC HYPOCHROMIC ANEMIA
3209PDF: 1712HTML: 14689Untitled: 273Untitled: 219 -
-
HEMATOPOIETIC STEM CELL TRNSPLANTATION IN THALASSEMIA AND RELATED DISORDERS
2028PDF: 537HTML: 4055 -
Sterile "Abscess" of the Spleen and the Sickle Cell Trait
3010PDF: 756HTML: 849 -
Thalassemia carrier detection among pregnant women Thalassemia carrier detection among pregnant women
2223PDF: 759HTML: 352 -
PROGNOSTIC FACTORS IN HODGKIN LYMPHOMA
3569PDF: 2110HTML: 7589 -
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
2154PDF: 2045HTML: 813 -
VITAMIN D STATUS IN THALASSEMIA MAJOR: AN UPDATE
2933PDF: 1192HTML: 2701 -
Coronavirus disease 2019 (COVID-19) severity in patients with thalassemias: A Nationwide Iranian Experience Coronavirus in patients with thalassemias
1593PDF: 578HTML: 212 -
High Prevalence of Antiphospholipid Antibodies in Children with Non-Transfusion Dependent Thalassemia and Possible Correlations with Microparticles Antiphospholipid Antibodies and Thalassemia in children
1180PDF: 694HTML: 331







